R

Revvity Inc
NYSE:RVTY

Watchlist Manager
Revvity Inc
NYSE:RVTY
Watchlist
Price: 112.34 USD 0.06% Market Closed
Market Cap: 13.7B USD
Have any thoughts about
Revvity Inc?
Write Note

Revvity Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Revvity Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
R
Revvity Inc
NYSE:RVTY
Retained Earnings
$5.8B
CAGR 3-Years
11%
CAGR 5-Years
16%
CAGR 10-Years
12%
Thermo Fisher Scientific Inc
NYSE:TMO
Retained Earnings
$51.4B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
18%
Danaher Corp
NYSE:DHR
Retained Earnings
$43.3B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
8%
Mettler-Toledo International Inc
NYSE:MTD
Retained Earnings
$8.1B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
14%
Agilent Technologies Inc
NYSE:A
Retained Earnings
$750m
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
IQVIA Holdings Inc
NYSE:IQV
Retained Earnings
$5.6B
CAGR 3-Years
43%
CAGR 5-Years
42%
CAGR 10-Years
N/A
No Stocks Found

Revvity Inc
Glance View

Market Cap
13.7B USD
Industry
Life Sciences Tools & Services
Economic Moat
None

In the fast-evolving landscape of life sciences and diagnostics, Revvity Inc. stands as a vital player, driving innovation and delivering critical solutions to a diverse array of sectors. Established with a focus on precision, Revvity leverages its expertise in diagnostics and scientific services to address pressing global health challenges. The company operates by providing advanced analytical instruments, reagents, and software, enabling researchers and healthcare providers to conduct intricate analyses with unmatched reliability. Their offerings are crucial in areas such as prenatal and neonatal screening, as well as infectious disease detection, where accuracy is of paramount importance. Revenue generation at Revvity hinges on a hybrid model that includes product sales, service contracts, and licensing. By supplying state-of-the-art laboratory equipment, along with complementary services and software, the company creates a comprehensive ecosystem for research and diagnostic testing. The breadth of their portfolio appeals to a varied clientele, from hospital labs to large research institutions, ensuring a steady and diversified income stream. Furthermore, their commitment to research and development fosters long-term partnerships and secures their place at the forefront of scientific advancement, making Revvity a linchpin in both the healthcare and scientific communities.

RVTY Intrinsic Value
106.53 USD
Overvaluation 5%
Intrinsic Value
Price
R

See Also

What is Revvity Inc's Retained Earnings?
Retained Earnings
5.8B USD

Based on the financial report for Sep 29, 2024, Revvity Inc's Retained Earnings amounts to 5.8B USD.

What is Revvity Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
12%

Over the last year, the Retained Earnings growth was 4%. The average annual Retained Earnings growth rates for Revvity Inc have been 11% over the past three years , 16% over the past five years , and 12% over the past ten years .

Back to Top